These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17947383)

  • 1. Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.
    Nahoum V; Pérez E; Germain P; Rodríguez-Barrios F; Manzo F; Kammerer S; Lemaire G; Hirsch O; Royer CA; Gronemeyer H; de Lera AR; Bourguet W
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17323-8. PubMed ID: 17947383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "Phantom Effect" of the Rexinoid LG100754: structural and functional insights.
    Sato Y; Ramalanjaona N; Huet T; Potier N; Osz J; Antony P; Peluso-Iltis C; Poussin-Courmontagne P; Ennifar E; Mély Y; Dejaegere A; Moras D; Rochel N
    PLoS One; 2010 Nov; 5(11):e15119. PubMed ID: 21152046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
    Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
    J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.
    Boerma LJ; Xia G; Qui C; Cox BD; Chalmers MJ; Smith CD; Lobo-Ruppert S; Griffin PR; Muccio DD; Renfrow MB
    J Biol Chem; 2014 Jan; 289(2):814-26. PubMed ID: 24187139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand Design for Modulation of RXR Functions.
    Martínez C; Souto JA; de Lera AR
    Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid receptors and therapeutic applications of RAR/RXR modulators.
    le Maire A; Alvarez S; Shankaranarayanan P; Lera AR; Bourguet W; Gronemeyer H
    Curr Top Med Chem; 2012; 12(6):505-27. PubMed ID: 22242853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor.
    Su Y; Zeng Z; Chen Z; Xu D; Zhang W; Zhang XK
    Curr Top Med Chem; 2017; 17(6):663-675. PubMed ID: 27320331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
    Dominguez M; Alvarez S; de Lera AR
    Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and in vitro characterization of RXR variants as tools to investigate the biological role of endogenous rexinoids.
    le Maire A; Rey M; Vivat V; Guée L; Blanc P; Malosse C; Chamot-Rooke J; Germain P; Bourguet W
    J Mol Endocrinol; 2022 Oct; 69(3):377-390. PubMed ID: 35900852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional insights into the ligand-binding domain of a nonduplicated retinoid X nuclear receptor from the invertebrate chordate amphioxus.
    Tocchini-Valentini GD; Rochel N; Escriva H; Germain P; Peluso-Iltis C; Paris M; Sanglier-Cianferani S; Van Dorsselaer A; Moras D; Laudet V
    J Biol Chem; 2009 Jan; 284(3):1938-48. PubMed ID: 18986992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
    Wagner CE; Jurutka PW
    Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.
    Zhang H; Li L; Chen L; Hu L; Jiang H; Shen X
    J Mol Biol; 2011 Mar; 407(1):13-20. PubMed ID: 21262235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations.
    le Maire A; Teyssier C; Balaguer P; Bourguet W; Germain P
    Cells; 2019 Nov; 8(11):. PubMed ID: 31694317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structural basis for the specificity of retinoid-X receptor-selective agonists: new insights into the role of helix H12.
    Love JD; Gooch JT; Benko S; Li C; Nagy L; Chatterjee VK; Evans RM; Schwabe JW
    J Biol Chem; 2002 Mar; 277(13):11385-91. PubMed ID: 11782480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The retinoid X receptor: a nuclear receptor that modulates the sleep-wake cycle in rats.
    Murillo-Rodríguez E; Millán-Aldaco D; Arankowsky-Sandoval G; Yamamoto T; Cid L; Monteiro D; Rocha NB; Telles-Correia D; Teixeira DS; Veras AB; Budde H; Machado S; Imperatori C; Torterolo P
    Psychopharmacology (Berl); 2020 Jul; 237(7):2055-2073. PubMed ID: 32472163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potency.
    Ohsawa F; Yamada S; Yakushiji N; Shinozaki R; Nakayama M; Kawata K; Hagaya M; Kobayashi T; Kohara K; Furusawa Y; Fujiwara C; Ohta Y; Makishima M; Naitou H; Tai A; Yoshikawa Y; Yasui H; Kakuta H
    J Med Chem; 2013 Mar; 56(5):1865-77. PubMed ID: 23391145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling, synthesis, and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic acid (CD3254).
    Jurutka PW; Kaneko I; Yang J; Bhogal JS; Swierski JC; Tabacaru CR; Montano LA; Huynh CC; Jama RA; Mahelona RD; Sarnowski JT; Marcus LM; Quezada A; Lemming B; Tedesco MA; Fischer AJ; Mohamed SA; Ziller JW; Ma N; Gray GM; van der Vaart A; Marshall PA; Wagner CE
    J Med Chem; 2013 Nov; 56(21):8432-54. PubMed ID: 24180745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative retinoid X receptor (RXR) ligands.
    Krężel W; Rühl R; de Lera AR
    Mol Cell Endocrinol; 2019 Jul; 491():110436. PubMed ID: 31026478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.